Related Experiment Video
Updated: Mar 29, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Candidemia in Southern Poland (2017-2022): Multicenter Analysis of Species Distribution and Antifungal Susceptibility
Magdalena Namysł1, Magdalena Skóra2, Monika Pomorska-Wesołowska3
1Department of Microbiology, University Hospital in Krakow, Jakubowskiego 2 Street, 30-688 Krakow, Poland.
Abstract:
Candida fungi are among the most common human fungal pathogens and invasive candidiasis is one of the predominant invasive mycoses that mainly affects hospitalized patients with suppression of the immunological system and breaches in skin or mucosal barriers. Rapid diagnosis and implementation of appropriate antifungal treatment are key to achieving recovery. In recent years, attention has been drawn to the increasing significance of Candida species other than C. albicans, in particular C. auris and fluconazole-resistant C. parapsilosis. The aim of this work was to present the species spectrum and drug susceptibility of 570 Candida strains isolated from candidemia cases diagnosed in patients hospitalized in southern Poland in the period 2017-2022. The results of Candida-positive blood cultures obtained from five hospitals were analyzed. C. albicans was the most common species, accounting for 42.6% of all strains, followed by Nakaseomyces glabratus (formerly C. glabrata) and C. parapsilosis complex-22.1% and 18.8%, respectively. No C. auris was found. Fluconazole resistance was found in 4.9% of C. albicans strains, 34.7% of N. glabratus strains, and 8.7% of C. parapsilosis complex strains.
Insights
This study analyzed 570 Candida strains from Polish hospitals (2017-2022). Candida albicans was most common, but resistance was noted in Nakaseomyces glabratus and Candida parapsilosis, highlighting the need for antifungal stewardship.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Clinical Microbiology
Background:
- Invasive candidiasis is a significant threat, particularly in immunocompromised hospitalized patients.
- Emerging non-albicans Candida species and antifungal resistance necessitate ongoing surveillance.
- Accurate species identification and susceptibility testing are crucial for effective treatment.
Purpose of the Study:
- To determine the species distribution of Candida causing candidemia in southern Poland from 2017-2022.
- To assess the antifungal drug susceptibility patterns of isolated Candida strains.
- To identify trends in non-albicans Candida prevalence and resistance.
Main Methods:
- Retrospective analysis of 570 Candida-positive blood cultures from five hospitals.
- Species identification of isolated Candida strains.
- Antifungal susceptibility testing, focusing on fluconazole resistance.
Main Results:
- Candida albicans was the most frequent species (42.6%).
- Nakaseomyces glabratus (formerly Candida glabrata) and Candida parapsilosis complex were the next most common (22.1% and 18.8%).
- Fluconazole resistance was observed in 4.9% of C. albicans, 34.7% of N. glabratus, and 8.7% of C. parapsilosis strains. No Candida auris was detected.
Conclusions:
- Candida albicans remains the leading cause of candidemia in the studied region.
- Significant fluconazole resistance rates were found in Nakaseomyces glabratus and Candida parapsilosis, underscoring treatment challenges.
- Continuous monitoring of Candida species spectrum and antifungal resistance is essential for public health.
More Related Videos
09:06Author Spotlight: Photodynamic Therapy as a Novel Approach to Induce Petite Colonies in Drug-Resistant Candida for Antifungal Research
Published on: March 29, 2024
07:19A 96 Well Microtiter Plate-based Method for Monitoring Formation and Antifungal Susceptibility Testing of Candida albicans Biofilms
Published on: October 21, 2010
Related Concept Videos
Antifungal Agents
Fungal Phylum Microsporidia
Fungal Group Zygomycota
Fungal Phylum Ascomycota